Inhaler trial aims to fight fatal lung scarring disease
Disease control
Recruiting now
This study is testing an experimental inhaled medicine called LTI-03 for people with Idiopathic Pulmonary Fibrosis (IPF), a serious disease that causes progressive lung scarring. About 120 participants will use an inhaler with either LTI-03 or a placebo for 24 weeks to see if the…
Phase: PHASE2 • Sponsor: Rein Therapeutics • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC